Dina Elantably

机构：Jacksonville College, WinnMed, Mayo Clinic in Florida, UNC Lineberger Comprehensive Cancer Center · ORCID：0000-0002-4706-3864

发表论文 39 篇 · 总被引 84 次 · h-index 5

代表论文

• CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study (2023 · Bone Marrow Transplantation · 被引 20)
• The association between body mass index and immune checkpoint inhibitors outcomes in melanoma: Results from real-world data. (2023 · Journal of Clinical Oncology · 被引 3)
• Intraperitoneal Chemotherapy Strategies in Pancreatic Ductal Adenocarcinoma: A Systematic Review of Hyperthermic Intraperitoneal Chemotherapy, Normothermic Intraperitoneal Chemotherapy, and Pressurized Intraperitoneal Aerosol Chemotherapy (2026 · Cancers · 被引 2)
• Validation of the Plasmic Score and Development of a Novel Predictive Model for Thrombotic Thrombocytopenic Purpura: Exploring Socioeconomic Disparities and Outcomes (2023 · Blood · 被引 2)
• Trends and survival of malignant mesothelioma across racial groups between 2000-2019: A real-world study. (2023 · Journal of Clinical Oncology · 被引 2)
• A pilot single-arm, pragmatic trial in progress of in-home versus in-clinic subcutaneous nivolumab administration through Cancer Care (connected access and remote expertise) Beyond Walls (CCBW) program. (2025 · Journal of Clinical Oncology · 被引 1)